Sanger sequencing market to reach $7.12 billion by 2030 at 16.7% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Sanger Sequencing Market Projected To Reach By 2030?

The sanger sequencing market has expanded considerably over recent years. Its valuation is projected to rise from $3.29 billion in 2025 to $3.85 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.1%. This historical growth can be linked to the initial widespread embrace of sanger sequencing as the definitive standard, a surge in genomics research by academic institutions and governments, an increase in genetic disorder testing, its growing application in forensic investigations, and heightened activity in pharmaceutical research and development.

The sanger sequencing market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $7.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.7%. Several factors are driving this anticipated growth, including the continuous requirement for validation sequencing in conjunction with NGS, the expansion of personalized medicine uses, an increasing need for economical targeted sequencing, the development of clinical diagnostics in nascent economies, and more partnerships between biotechnology companies and research organizations. Key trends anticipated during this period involve the persistent utilization of sanger sequencing to confirm NGS outcomes, a consistent need for targeted gene sequencing in diagnostic procedures, its expanding utility in biomarker and cancer investigations, the rising practice of delegating sequencing tasks to expert laboratories, and its continued application in forensic science and reproductive health examinations.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13925&type=smp

What Factors Are Contributing To The Growth Of The Sanger Sequencing Market?

An anticipated increase in genetic illnesses is projected to fuel the expansion of the sanger sequencing market going forward. A genetic illness, also known as a genetic disorder, refers to a health condition resulting from irregularities or changes within an individual’s DNA, which is the inherited material containing genetic data. Sanger sequencing serves as a diagnostic tool for genetic illnesses, accurately identifying the sequence of nucleotides (DNA’s fundamental components) within a particular gene or DNA segment. As an illustration, figures from August 2024, provided by the National Health Service, a publicly funded healthcare system located in the UK, indicate that approximately 2,300 individuals in the UK were affected by thalassaemia in 2024. Of these, around 800 suffer from the severe variant of the disease and require consistent blood transfusions. Consequently, the growing prevalence of genetic illness is a key factor propelling the growth of the sanger sequencing market.

What Segment Categories Shape The Sanger Sequencing Market Segment Landscape?

The sanger sequencing market covered in this report is segmented –

1) By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing

2) By Laboratory: Wet Labs, Dry Labs

3) By Research: In-House, Outsourced

4) By Application: Diagnostics, Biomarkers And Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications

5) By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics

Subsegments:

1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing, Metagenomic Shotgun Sequencing

2) By Targeted Gene Sequencing: Amplicon Sequencing, Exome Sequencing

3) By Other Sequencing: Nested PCR Sequencing, Capillary Electrophoresis Based Sanger Sequencing

What Trends Are Shaping The Future Of The Sanger Sequencing Market?

Leading companies in the sanger sequencing market are strategically expanding their genomic laboratories to offer prompt sanger sequencing services to the UK’s northern region. Genomic laboratories are specialized centers that conduct genetic testing and analysis, delving into the structure, function, and inheritance of genes and genomes, frequently for diagnostic purposes, scientific investigation, and personalized medical approaches. For instance, in June 2023, Source Genomics, a UK company specializing in genomic services, announced the expansion of their genomic laboratory into the UK’s north. This move is set to increase the capacity of their Sanger sequencing services and accelerate data delivery turnaround times. Extending laboratory operations to these northern territories represents a significant step forward in ensuring equitable access to genomic services for research organizations across the nation. This regional development will enable customers nationwide to benefit from high-quality Sanger sequencing services delivered with improved efficiency.

Who Are The Companies Operating Across The Sanger Sequencing Market Value Chain?

Major companies operating in the sanger sequencing market are Hoffmann La Roche, Thermo Fisher Scientific Inc, Merck KGaA, Eurofins Scientific, Beckman Coulter, PerkinElmer Inc, LGC Limited, GenScript, Macrogen Inc, GENEWIZ Inc, Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty Ltd, SciGenom Labs Pvt Ltd, StarSEQ GmbH, GATC Biotech AG, Agilent Technologies, Azenta Life Sciences, CD Genomics, Novogene Sanger Services

Get The Full Sanger Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report

Which Region Has The Greatest Market Share In The Sanger Sequencing Market?

North America was the largest region in the sanger sequencing market in 2025. The regions covered in the sanger sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Sanger Sequencing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report

Browse Through More Reports Similar to the Global Sanger Sequencing Market 2026, By The Business Research Company

Next Generation Sequencing Market

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Short Read Sequencing Market Report

https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report

Dna Sequencing Market Report

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795